HODSON AND GEDDES CYSTIC FIBROSIS 5ED (HB 2024) Hardcover

The Fifth Edition of "Cystic Fibrosis" reflects the significant progress in treatment since the previous edition, notably the development of targeted CFTR protein modulators effective for most CFTR gene mutations. This new edition updates and expands on the rapid clinical and scientific advancements that have improved the outlook for individuals with CF, and it also addresses the impact of COVID-19, all of which has reshaped traditional care approaches. The book covers fundamental science, illustrating how a deep understanding of the CFTR gene and protein biology has led to innovative and beneficial therapies. Additionally, it addresses all aspects of clinical management in various economic settings (high-, middle-, and low-income) and includes personal experiences from individuals with CF worldwide. This will be a valuable resource for clinicians at all training levels, the entire multidisciplinary team, scientists, and students.